Host genetic control of gut fungal genera: genus-specific regulation of Malassezia, Saccharomyces and Aspergillus abundance, and overlap with autoimmune liver disease loci
Abstract Background How much of gut fungal abundance is under host genetic control, and whether the same loci contribute to autoimmune liver disease (AILD), is not well mapped. Methods We used gut mycobiome genome-wide association study (GWAS) summary statistics (N = 7,350) for Malassezia , Saccharomyces and Aspergillus abundance, and AILD GWAS for primary biliary cholangitis (PBC, N = 24,510), primary sclerosing cholangitis (PSC, N = 14,890) and autoimmune hepatitis (AIH, N = 485,234). Gene-based, gene-set and cell-type tests were run in MAGMA/FUMA with Bonferroni correction; colocalization, regional-overlap and cis-eQTL matching linked fungal and AILD loci under a triangulation framework. Results Host control was genus-specific: the two yeasts carried strong gene-level signal ( Malassezia 85, Saccharomyces 70 significant genes) with non-overlapping pathway signatures (intracellular processing versus leukocyte recruitment), while Aspergillus had none at gene level. On the disease side, PBC returned 381 significant genes and 217 significant gene sets led by adaptive-immunity themes, PSC returned 20 gene sets led by MHC class II antigen presentation, cell-type analysis placed Malassezia signals in myeloid and AILD signals in lymphoid compartments; no fungal genus showed gene-level signal in the HLA region. Drug-gene annotation identified SYK (fostamatinib, approved) as the most actionable node of the antifungal-recognition pathway. No fungal-AILD window reached formal colocalization (maximum PP.H4 = 0.16, reflecting limited power). One locus showed single-SNP concordance (chr4:130.2 Mb, C4orf33/SCLT1/PHF17), one strong cis-eQTL support (chr11, AIP cis-eQTL up to |Z| = 15.0), and one regional overlap alone (chr14). AIH yielded no testable window (insufficient variant overlap). Conclusions Gut fungal abundance exhibits genus-specific host genetic regulation. This first locus-level joint genetic analysis of gut mycobiome and AILD identifies prioritised candidate loci and immune pathways: two prioritised loci (chr4 with single-SNP triangulation, chr11 marked by strong AIP cis-eQTL) and the nominally associated IL-23R immune node; the gene-level structure is robust to ancestry-matched reanalysis, whereas SUMO pathway replication is panel-dependent. These candidates define where fungal and cholangitis genetics meet and are ready for functional follow-up. SYK-fostamatinib is the one annotated axis with an approved drug, untested in AILD; replication in ancestry-matched cohorts is pending.
Authors
- Xiaofan Xu (ORCID: https://orcid.org/0009-0004-2944-2168)
- Jian Sun
- Minli Liu¹
- Yifan Jin¹
- Shijing Gao¹
Institutions
- Wuxi Fourth People's Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-13
- DOI
- https://doi.org/10.21203/rs.3.rs-11478534/v1
- Primary Topic
- Liver Diseases and Immunity
- Type
- preprint